At a glance
- Originator sigma-tau SpA
- Class Antidementias; Basic amino acids; Diamino amino acids; Essential amino acids; Neuroprotectants; Small molecules
- Mechanism of Action Nerve growth factor stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cognition disorders
Most Recent Events
- 25 Jun 2001 No-Development-Reported for Cognition disorders in Italy (Unknown route)
- 25 May 1995 Preclinical development for Cognition disorders in Italy (Unknown route)